Evaluating the Immunogenicity of an Intranasal Microparticle Combination Vaccine for COVID-19 and Influenza

Evaluating the Immunogenicity of an Intranasal Microparticle Combination Vaccine for COVID-19 and Influenza

Background: Infectious respiratory pathogens like SARS-CoV-2 and influenza frequently mutate, leading to the emergence of variants. This necessitates continuous updates to FDA-approved vaccines with booster shots targeting the circulating variants. Vaccine hesitancy and needle injections create inco...

Full description

Saved in:
Bibliographic Details
Main Authors: Sharon Vijayanand, Smital Patil, Priyal Bagwe, Revanth Singh, Emmanuel Adediran, Martin J. D’Souza
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Vaccines
Subjects:
intranasal vaccine
infectious diseases
microparticles
immunogenicity
combination vaccine
COVID-19
Online Access:https://www.mdpi.com/2076-393X/13/3/282
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items